The RNA was then DNase treated before cDNA synthesis with Superscript III (Invitrogen, #18080051)
This investigational drug holds promise for millions suffering from debilitating pain, offering a potential alternative to current therapies that often provide only partial relief or come with significant side effects
Endocrinology 153: 3054-3065, 2012
Each modification solves a specific biological problem, and together they create a molecule with pharmacokinetic properties no natural peptide possesses
Together with the pharmacodynamic data, this PK knowledge may help in selecting dosing regimens needed to achieve target exposures that maximize efficacy and minimize toxicity, advancing the translation of 7,8-DHF therapy from preclinical to clinical studies
Metformin suppresses hepatic gluconeogenesis via AMPK activation, [6] while GLP-1 receptor agonists enhance glucose-dependent insulin secretion and promote satiety, improving both fasting and postprandial glycaemic control